Subscribe to PCE Communications
    Choose Your Subscription

    Healthcare Q3 2019

    Q3 Healthcare

    M&A Transaction Trends

    Largest Transactions Closed

    • Target
    • Buyer
    • Value($mm)

    Source S&P Capital IQ as of 10/10/2019 and PCE Proprietary Data

    M&A Industry Trends

    Amazon's Launched its Virtual Healthcare Service for Employees

    Amazon launched its pilot healthcare service for employees in the Seattle area. The service aims to provide Amazon employees with the flexibility to communicate with medical professionals over chat or video call. The initiative comes as a result of a partnership announced with J.P Morgan and Berkshire Hathaway. The move signals a broader trend among tech companies expansion into healthcare services, primarily medical consultation.1

    Mayo Clinic to Store Patient Data on Google's Cloud

    Google and the Mayo Clinic recently announced a partnership. Mayo will house its patient data on Google’s cloud. This news comes as both Microsoft Azure and Amazon Web Services partner up with healthcare providers to offer data storage and analytics. The cloud computing trend comes at a time when healthcare providers are consolidating as a way to ensure stronger value to patients. The ability to analyze massive troves of data provides physicians with better ways to identify signs of disease early-on and heightened accuracy to diagnoses.2, 3

    Otezla Purchase Goes for $13.4 Billion in Cash

    Healthcare deals continued at a robust pace through Q3. In August, Amgen announced plans to purchase the anti-inflammatory drug Otezla from Celegen for $13.4 billion in cash. Bristol-Myers Squibb is in talks to acquire Celegen for $74.0 billion. In Mid-August Bayer decided to sell its animal medicines business to Elanco Animal Health for $7.6 billion, this values the company at roughly 19.0x EBITDA.4

    Johnson & Johnson Fined $572 Million for Their Part in the Opioid Crisis

    An Oklahoma judge ruled that Johnson & Johnson exaggerated the benefits and downplayed the addictive qualities of opioids, ordering the manufacturer to pay a fine of $572 Million. Additionally, new legislation in Congress addresses the rising costs of hospital bills and has made investors bearish on healthcare. The share of junk-rated corporate loans has risen to 6.9% in the last month – the highest level since 2009.5, 6

    FDA Working to Prevent Misdiagnosis Within Mobile Apps

    The FDA announced new guidelines for mobile healthcare products that provide telemedicine services. The rules are meant to give some clarity as to precisely what services mobile apps can offer. The FDA hopes to prevent these tools from misdiagnosing patients, specifically higher risk diagnoses such as diabetes or forms of cancer.7

    Largest M&A Transactions Closed

    Target Buyer Value($mm)
    Array BioPharma Inc. Pfizer Inc. $11,499.34
    Xiidra of Shire US, Inc. Novartis AG $5,300.00
    Peloton Therapeutics, Inc. Merck & Co., Inc. $2,202.56
    Benchmark Senior Living Portfolio - $1,700.00
    Real Estate of 11 Acute Care Hospitals and 2 Behavioral Health Facilities MPT Operating Partnership, L.P. $1,400.00
    Exonics Therapeutics, Inc. Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX) $1,043.00
    Modis Therapeutics, Inc. Zogenix, Inc. $404.77
    Cavion LLC Jazz Pharmaceuticals plc $312.50
    SentreHEART, Inc. AtriCure, Inc. $300.00
    Aratana Therapeutics, Inc. Elanco Animal Health Incorporated $251.12

    Source S&P Capital IQ as of 10/10/2019 and PCE Proprietary Data

    New call-to-action

    Contacts

    Michael Poole

     

    Michael Poole

    Investment Banking | ESOP

     

    407-621-2112

    mpoole@pcecompanies.com

    David Jasmund

     

    David Jasmund

    Investment Banking | ESOP

     

    407-621-2111

    djasmund@pcecompanies.com


    Data Assumptions

    This report represents transaction activity as mergers & acquisitions, consolidations, restructurings and spin-offs. Targets are defined as U.S. Based companies with either foreign or U.S. based buyers. Transaction information provided is based on closed dates only.

    Glossary

    EBIT - Earnings Before Interest and Taxes
    EBITDA - Earnings Before Interest, Taxes, Depreciation, Amortization
    LTM - Last Twelve Months
    TEV - Total Enterprise Value

    Sources:

    1. Etherington, Darrell. “Amazon Launches Amazon Care, a Virtual and in-Person Healthcare Offering for Employees.” TechCrunch, TechCrunch, 24 Sept. 2019.
    2. Molteni, Megan. “AI Could Reinvent Medicine-Or Become a Patient's Nightmare.” Wired, Conde Nast, 19 Sept. 2019.
    3. Evans, Melanie. “Google, Amazon and Microsoft in Battle to Store Health Data in the Cloud.” The Wall Street Journal, Dow Jones & Company, 10 Sept. 2019.
    4. Grant, Charley. “Amgen Shows Price Is Still Right for Blockbuster Drug Deals.” The Wall Street Journal, Dow Jones & Company, 26 Aug. 2019.
    5. Hoffman, Jan. “Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial.” The New York Times, The New York Times, 26 Aug. 2019.
    6. Goldfarb, Sam. “Health-Care Turmoil Adds to Debt Investors' Concerns.” The Wall Street Journal, Dow Jones & Company, 27 Sept. 20191.
    7. Ross, Casey, and Casey. “FDA Clarifies How It Will Regulate Digital Health, Artificial Intelligence.” STAT, 26 Sept. 2019.
    David Jasmund

     

    David Jasmund

    Investment Banking | ESOP

    Orlando Office

    407-621-2111 (direct)

    djasmund@pcecompanies.com

    Connect
    407-621-2111 (direct)

    407-621-2199 (fax)

    Eric Zaleski

     

    Eric Zaleski

    Investment Banking | ESOP

    Chicago Office

    847-239-2466 (direct)

    ezaleski@pcecompanies.com

    Connect
    847-239-2466 (direct)

    407-621-2199 (fax)

    Melissa Ritter

     

    Melissa Ritter

    Investment Banking

    Orlando Office

    407-621-2128 (direct)

    mritter@pcecompanies.com

    Connect
    407-621-2128 (direct)

    407-621-2199 (fax)

    Michael Rosendahl

     

    Michael Rosendahl

    Investment Banking

    New York Office

    201-444-6280 Ext 1 (direct)

    mrosendahl@pcecompanies.com

    Connect
    201-444-6280 Ext 1 (direct)

    407-621-2199 (fax)

    Will Stewart

     

    Will Stewart

    Investment Banking | ESOP

    Orlando Office

    407-621-2124 (direct)

    wstewart@pcecompanies.com

    Connect
    407-621-2124 (direct)

    407-621-2199 (fax)

    whitcomb-woody

     

    Woody Whitcomb

    Investment Banking

    Orlando Office

    407-621-2113 (direct)

    wwhitcomb@pcecompanies.com

    Connect
    407-621-2113 (direct)

    407-621-2199 (fax)

    poole_michael

     

    Michael Poole

    Investment Banking

    Orlando Office

    407-621-2112 (direct)

    mpoole@pcecompanies.com

    Connect
    407-621-2112 (direct)

    407-621-2199 (fax)

    vogt-paul

     

    Paul Vogt

    Valuation

    Atlanta Office

    678-641-4760 (direct)

    pvogt@pcecompanies.com

    Connect
    678-641-4760 (direct)

    407-621-2199 (fax)

    Mackenzie Moran

     

    Mackenzie Moran

    Investment Banking

    New York Office

    201-444-6280 Ext 3 (direct)

    mmoran@pcecompanies.com

    Connect
    201-444-6280 Ext 3 (direct)

    407-621-2199 (fax)

    Isabel Carta

     

    Isabel Carta

    Investment Banking

    Orlando Office

    407-621-2149 (direct)

    icarta@pcecompanies.com

    Connect
    407-621-2149 (direct)

    407-621-2199 (fax)

    Philipp Seubert

     

    Philipp Seubert

    Investment Banking

    New York Office

    201-444-6280 Ext 4 (direct)

    pseubert@pcecompanies.com

    Connect
    201-444-6280 Ext 4 (direct)

    407-621-2199 (fax)

    Please Share This